Agilent Technologies Acquires BIOVECTRA for $925M
July 22, 2024
Agilent Technologies has acquired BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO), for $925 million. The acquisition — a purchase from H.I.G. Capital — expands Agilent's CDMO capabilities across biologics, HPAPIs, pDNA/mRNA and LNP formulation, and integrates BIOVECTRA into Agilent's Diagnostics and Genomics Group.
- Buyers
- Agilent Technologies Inc.
- Targets
- BIOVECTRA Inc.
- Sellers
- H.I.G. Capital
- Industry
- Pharmaceuticals
- Location
- Prince Edward Island, Canada
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.